Bradford Crutchfield, Chief Commercial Officer at 10x Genomics, Inc. (TXG), sold 20,475 shares at $124.26 ($2.6M) on 2020-10-01, disclosed to the SEC on 2020-10-05.
Open-market sale of $2.6M TXG by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $124.26 | 2,500 | $311K | 12.1% |
| 2 | $125.48 | 10,725 | $1.3M | 52.4% |
| 3 | $125.99 | 3,475 | $438K | 17.0% |
| 4 | $125.99 | 3,475 | $438K | 17.0% |
| 5 | $126.88 | 300 | $38K | 1.5% |
| Total | $125.52 avg | 20,475 |
| $2.6M |
| 100% |
| Filing → |
| TXG | SELL | 2022-02-24 | $23K | — | Filing → |
| TXG | SELL | 2022-02-17 | $1.6M | — | Filing → |
| TXG | SELL | 2022-01-14 | $3.5M | — | Filing → |